An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine

BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech, New York, NY, USA), is one of the most effective COVID-19 vaccines and has been approved by more than 130 countries worldwide. However, several studies have reported that the COVID-19 vaccine shows high interpersonal variability in terms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khor, Seik-Soon, Omae, Yosuke, Takeuchi, Junko S., Fukunaga, Ami, Yamamoto, Shohei, Tanaka, Akihito, Matsuda, Kouki, Kimura, Moto, Maeda, Kenji, Ueda, Gohzoh, Mizoue, Tetsuya, Ujiie, Mugen, Mitsuya, Hiroaki, Ohmagari, Norio, Sugiura, Wataru, Tokunaga, Katsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029840/
https://www.ncbi.nlm.nih.gov/pubmed/35455312
http://dx.doi.org/10.3390/vaccines10040563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029840/
https://www.ncbi.nlm.nih.gov/pubmed/35455312
http://dx.doi.org/10.3390/vaccines10040563

Ejemplares similares